{"id":"NCT00350779","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)","officialTitle":"A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin (MK0431) in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Metformin and a PPARg Agonist","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06-12","primaryCompletion":"2007-09-25","completion":"2008-06-11","firstPosted":"2006-07-11","resultsPosted":"2009-07-03","lastUpdate":"2017-05-12"},"enrollment":262,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"sitagliptin","otherNames":["Januvia"]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]},{"type":"DRUG","name":"rosiglitazone","otherNames":["Avandia"]},{"type":"DRUG","name":"metformin","otherNames":[]},{"type":"DRUG","name":"glipizide","otherNames":["Glucotrol"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin/peroxisome proliferator-activated receptor gamma (PPARg) agonist combination therapy.","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Hemoglobin A1C) at Week 18","timeFrame":"Baseline and 18 Weeks","effectByArm":[{"arm":"Sitagliptin 100 mg","deltaMin":-1.03,"sd":null},{"arm":"Placebo","deltaMin":-0.31,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22742523"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2},"commonTop":["Any Infections And Infestations","Upper Respiratory Tract Infection","Nasopharyngitis","Any Nervous System Disorders","Any General Disorders And Administration Site Conditions"]}}